Related Experiment Video
Updated: Feb 16, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Fragment-based discovery of a potent NAMPT inhibitor
Alla Korepanova1, Kenton L Longenecker1, Steve D Pratt1
1Research & Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, United States.
Researchers identified novel small molecule binders for NAMPT (Nicotinamide phosphoribosyltransferase), a protein targeted in cancer therapy. Elaboration of a key fragment led to a potent NAMPT inhibitor, offering new therapeutic strategies.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Structural Biology
Background:
- Nicotinamide phosphoribosyltransferase (NAMPT) is upregulated in various cancers, presenting it as a viable target for anticancer drug development.
- Identifying novel inhibitors of NAMPT is crucial for advancing cancer therapeutics.
Purpose of the Study:
- To discover and characterize novel small molecule binders of human NAMPT.
- To use structural information to develop potent NAMPT inhibitors for potential anticancer applications.
Main Methods:
- Fragment screening using Nuclear Magnetic Resonance (NMR) and Time-Resolved Förster Resonance Energy Transfer (TR-FRET).
- X-ray crystallography to determine co-crystal structures of NAMPT with bound fragments.
- Force-field driven molecular docking to predict fragment binding poses.
- Structure-based drug design for inhibitor elaboration.
Main Results:
- Six novel NAMPT binders were identified with varying potencies.
- Co-crystal structures were obtained for two binders, providing detailed structural insights.
- Docking studies generated plausible binding poses for the remaining four binders.
- One fragment was successfully elaborated into a potent NAMPT inhibitor based on structural analysis.
Conclusions:
- Novel chemical matter targeting NAMPT has been discovered.
- Structural insights facilitate the rational design of potent NAMPT inhibitors.
- The identified potent inhibitor represents a promising lead for anticancer drug development.
Related Concept Videos
Habitat Fragmentation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Drug Discovery: Overview
Mass Spectrometry: Alkene Fragmentation
Mass Spectrometry: Amine Fragmentation
In amines, the number of nitrogen atoms affects the mass of the molecular ion, which is described by the nitrogen rule of mass spectrometry. This rule states that a compound containing a single...
Mass Spectrometry: Cycloalkane Fragmentation
For example, cyclohexane molecular ions have a mass-to-charge ratio (m/z) of 84, which tends to produce a stronger signal than linear alkanes like hexane. This stability comes from...

